The role of PIAS1 in inflammation and immune disorders
The role of PIAS1 in inflammation and immune disorders
批准号:
7098665
负责人:
BIN LIU
金额:
$12.85万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pro-inflammatory cytokines play important roles in mediating inflammation and immune responses. Dysregulation of cytokine functions has been implicated in autoimmune diseases, such as arthritis. Cytokines exert their biological functions by activating multiple signaling cascades, including STAT and NF-kB pathways. My long-term research goal is to understand cytokine signaling and immune regulation. We have identified a novel family of proteins named PIAS (protein inhibitor of activated STAT), which negatively regulates STAT signaling. Our recent studies revealed that PIAS1 is also an inhibitor of NF- kB , and that PIAS1 plays an important role in controlling the pro-inflammatory cytokine production in vivo. The overall goal of this proposal is to further study the mechanism and function of PIAS1 in NF-kB signaling, proinflammatory cytokine production and arthritis using combined biochemical and genetic approaches. First, we will study the molecular mechanism of PIAS1-mediated inhibition on NF- kB. We will address the specificity of PIAS1-mediated inhibition on NF- kB -dependent genes. We will examine the importance of SUMO E3 ligase activity of PIAS1 in NF- kB signaling. We will also study the involvement of other PIAS proteins in the regulation of NF- kB . Second, we will address the mechanism of PIAS1-mediated regulation of pro-inflammatory cytokine production. We will study PIAS1-mediated regulation of cytokine production at both transcriptional and posttranslational levels. Third, we will address the in vivo role of PIAS1 in the pathogenesis of arthritis using various animal models. We will examine the possible mechanisms of PIAS1- mediated action in arthritis models. We will also study the involvement of STAT1 signaling in arthritis pathogenesis. These studies will provide further understanding of the role of PIAS1 in inflammation and immune diseases and may identify novel targets for therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combination antigen sensing engineered T cell for precise recognition and enhanced elimination of solid tumors
-
批准号:10651062
-
项目类别:
-
资助金额:$66.61万
-
财政年份:2023
-
负责人:BIN LIU
-
依托单位:
Novel Proteomic Approaches for the Study of Alcohol Neuropathology
-
批准号:8893487
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2015
-
负责人:BIN LIU
-
依托单位:
Role of Microglia in Ethanol-induced Oxidative Stress
-
批准号:8712304
-
项目类别:
-
资助金额:$16.98万
-
财政年份:2013
-
负责人:BIN LIU
-
依托单位:
Role of Microglia in Ethanol-induced Oxidative Stress
-
批准号:8445822
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2013
-
负责人:BIN LIU
-
依托单位:
Internalizing human antibody-targeted nanosized siRNA therapeutics
-
批准号:8391664
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2012
-
负责人:BIN LIU
-
依托单位:
Internalizing human antibody-targeted nanosized siRNA therapeutics
-
批准号:8893025
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2012
-
负责人:BIN LIU
-
依托单位:
Internalizing human antibody-targeted nanosized siRNA therapeutics
-
批准号:8523809
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2012
-
负责人:BIN LIU
-
依托单位:
Internalizing human antibody-targeted nanosized siRNA therapeutics
-
批准号:8702119
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2012
-
负责人:BIN LIU
-
依托单位:
Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma
-
批准号:8403611
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2010
-
负责人:BIN LIU
-
依托单位:
Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma
-
批准号:7888421
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2010
-
负责人:BIN LIU
-
依托单位:
Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma
-
批准号:8016065
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2010
-
负责人:BIN LIU
-
依托单位:
Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma
-
批准号:8209276
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2010
-
负责人:BIN LIU
-
依托单位:
Selection of internalizing human antibodies targeting pancreatic tumor cells in s
-
批准号:7760525
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2009
-
负责人:BIN LIU
-
依托单位:
Selection of internalizing human antibodies targeting pancreatic tumor cells in s
-
批准号:7660256
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2009
-
负责人:BIN LIU
-
依托单位:
Internalizing antibody-targeted nanosized siRNA therapeutics
-
批准号:7744706
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2008
-
负责人:BIN LIU
-
依托单位:
Internalizing antibody-targeted nanosized siRNA therapeutics
-
批准号:7588691
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2008
-
负责人:BIN LIU
-
依托单位:
Mapping a clinically significant internalizing tumor epitope space
-
批准号:8115751
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:BIN LIU
-
依托单位:
Mapping a clinically significant internalizing tumor epitope space.
-
批准号:7367198
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2006
-
负责人:BIN LIU
-
依托单位:
Mapping a clinically significant internalizing tumor epitope space.
-
批准号:7196540
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2006
-
负责人:BIN LIU
-
依托单位:
Mapping a clinically significant internalizing tumor epitope space
-
批准号:8277976
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:BIN LIU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: